Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

VIRGILIO GERALD H EVIDENTE

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1730163353
CMS profile
351522
Location
SCOTTSDALE, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$39,625.79

150 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 150 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

VIRGILIO GERALD H EVIDENTE

NPI 1730163353 · CMS profile ID 351522

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

SCOTTSDALE, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 150 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1730163353?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
VIRGILIO GERALD H EVIDENTE, NPI 1730163353, CMS profile ID 351522. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 150 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1730163353?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). VIRGILIO GERALD H EVIDENTE, NPI 1730163353, CMS profile ID 351522. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 150 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1730163353?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
VIRGILIO GERALD H EVIDENTE, NPI 1730163353, CMS profile ID 351522, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 150 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1730163353?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

150 matching records · $39,625.79 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 150 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 150.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
UCB, Inc. $6.2309/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746091699 CMS
Kyowa Kirin, Inc. $2,115.0009/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746868367 CMS
Adamas Pharmaceuticals, Inc. $12.9609/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750008101 CMS
Ipsen Biopharmaceuticals, Inc $15.7209/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741942073 CMS
Acorda Therapeutics, Inc $17.6609/01/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 716697961 CMS
Medtronic USA, Inc. $16.8808/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735687657 CMS
AbbVie Inc. $18.7708/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721776857 CMS
Teva Pharmaceuticals USA, Inc. $7.9508/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749535263 CMS
Kyowa Kirin, Inc. $14.3608/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746868361 CMS
UCB, Inc. $21.6008/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746083125 CMS
Adamas Pharmaceuticals, Inc. $13.8608/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750008099 CMS
Teva Pharmaceuticals USA, Inc. $110.5008/12/2020 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749452639 CMS
Teva Pharmaceuticals USA, Inc. $15.6308/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749466387 CMS
Teva Pharmaceuticals USA, Inc. $88.4908/12/2020 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749482157 CMS
Medtronic USA, Inc. $21.8908/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735674275 CMS
UCB, Inc. $8.2908/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746086289 CMS
Lundbeck LLC $17.1608/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747520203 CMS
Ipsen Biopharmaceuticals, Inc $16.7108/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741941147 CMS
Medtronic USA, Inc. $22.5107/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735674273 CMS
Kyowa Kirin, Inc. $13.5107/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746868355 CMS
AbbVie Inc. $18.5407/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721776851 CMS
UCB, Inc. $22.7007/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746086703 CMS
Neurocrine Biosciences, Inc. $18.8207/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748921075 CMS
Teva Pharmaceuticals USA, Inc. $3,535.0007/16/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749517555 CMS
ACADIA Pharmaceuticals Inc $16.9307/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748555151 CMS
Teva Pharmaceuticals USA, Inc. $2,080.0007/14/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749521887 CMS
Acorda Therapeutics, Inc $17.6107/13/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 716697959 CMS
Adamas Pharmaceuticals, Inc. $12.9707/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750008097 CMS
Medtronic USA, Inc. $8.0007/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735663421 CMS
Medtronic USA, Inc. $19.5107/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735663419 CMS
Teva Pharmaceuticals USA, Inc. $19.7007/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749512853 CMS
AbbVie Inc. $16.7406/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721776847 CMS
Kyowa Kirin, Inc. $16.0906/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746868351 CMS
Teva Pharmaceuticals USA, Inc. $7.7106/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749482835 CMS
Neurocrine Biosciences, Inc. $14.5806/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748921073 CMS
Medtronic USA, Inc. $5.3806/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735653931 CMS
Lundbeck LLC $1,600.0006/11/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747520199 CMS
ACADIA Pharmaceuticals Inc $14.2206/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748555147 CMS
UCB, Inc. $16.9606/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746065439 CMS
Boston Scientific Corporation $22.3106/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725605595 CMS
AbbVie Inc. $18.2905/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721776843 CMS
Kyowa Kirin, Inc. $20.0005/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746868347 CMS
MERZ NORTH AMERICA, INC. $20.5705/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737049291 CMS
Medtronic USA, Inc. $19.4205/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735651215 CMS
Acorda Therapeutics, Inc $21.1205/13/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 716697957 CMS
Lundbeck LLC $13.0205/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747520195 CMS
UCB, Inc. $16.7705/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746054983 CMS
Neurocrine Biosciences, Inc. $18.0705/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748921071 CMS
Teva Pharmaceuticals USA, Inc. $9.9104/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749453489 CMS
Medtronic USA, Inc. $11.7304/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735651211 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $22,672.59 156
PY2020 $39,625.79 150
PY2021 $14,591.56 155
PY2022 $28,742.40 168
PY2023 $19,890.20 191
PY2024 $34,145.15 188
PY2025 $71,586.38 216

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $20,910.44 12
PY2024 Principal investigator $83,695.74 55
PY2023 Recipient $1,500.00 1
PY2023 Principal investigator $24,317.35 5
PY2022 Principal investigator $92,695.58 20
PY2021 Principal investigator $147,172.66 23
PY2020 Recipient $8,000.00 1
PY2020 Principal investigator $37,856.00 10
PY2019 Recipient $12,000.00 2
PY2019 Principal investigator $75,749.61 11

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Ipsen Pharma SAS $2,000.00 12/30/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304185
Principal investigator 1 Ipsen Pharma SAS $1,250.00 12/30/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304187
Principal investigator 1 Ipsen Pharma SAS $1,987.38 08/08/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304171
Principal investigator 1 Ipsen Pharma SAS $1,987.38 08/08/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304173
Principal investigator 1 Ipsen Pharma SAS $1,832.97 08/08/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304175
Principal investigator 1 Ipsen Pharma SAS $1,987.38 08/08/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304177
Principal investigator 1 Ipsen Pharma SAS $1,987.38 08/08/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304179
Principal investigator 1 Ipsen Pharma SAS $1,832.97 08/08/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304181
Principal investigator 1 Ipsen Pharma SAS $1,832.97 08/08/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304183
Principal investigator 1 Ipsen Pharma SAS $1,906.13 04/01/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304169
Principal investigator 1 Ipsen Pharma SAS $1,101.75 02/17/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304167
Principal investigator 1 Ipsen Pharma SAS $1,204.13 01/29/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304165